Floxuridine
USP/1271008 - United States Pharmacopeia (USP) Reference Standard
Synonym: 5-Fluoro-2′-deoxyuridine; 2′-Deoxy-5-fluorouridine; FUDR; Floxuridine
CAS Number: 50-91-9
Empirical Formula (Hill Notation): C9H11FN2O5
Molecular Weight: 246.19
MDL Number: MFCD00006530
Linear Formula: C9H11FN2O5
Product Type: Chemical
| API family | floxuridine |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C9H11FN2O5/c10-4-2-12( |
| InChI key | ODKNJVUHOIMIIZ-RRKCRQDMSA |
| manufacturer/tradename | USP |
| mp | 148 °C (lit.) |
| SMILES string | OC[C@H]1O[C@H](C[C@@H]1O) |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Floxuridine USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Floxuridine for Injection |
| Biochem/physiol Actions: | Antineoplastic drug that acts as a potent inhibitor of thymidylate synthetase Resistance to FUdR can develop in cancer cell cultures, among other means, by low-level Mycoplasma infection. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: | Sales restrictions may apply. |
| Symbol |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P330 + P331 + P310 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| mp | 148 °C (lit.) |
| UNSPSC | 41116107 |